-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Sell on Integra Lifesciences, Raises Price Target to $11

Benzinga·05/06/2026 19:11:44
Listen to the news
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and raises the price target from $9 to $11.